Status:
NOT_YET_RECRUITING
Gasdermin D Expression in Generalized Vitiligo Patients After Narrow-band Ultraviolet B Therapy
Lead Sponsor:
South Valley University
Conditions:
Vitiligo, Generalized
Eligibility:
All Genders
10-75 years
Phase:
NA
Brief Summary
The aim of this study is to: 1. Evaluate the role of tissue Gasdermin D expression using immunehistochemstry techniques in patients with generalized vitiligo and compare it with healthy controls. 2. ...
Detailed Description
The aim of this study is to: 1. Evaluate the role of tissue Gasdermin D expression using immunehistochemstry techniques in patients with generalized vitiligo and compare it with healthy controls. 2. ...
Eligibility Criteria
Inclusion
- Patients with stable vitiligo of 6 months duration,
- Both sex and ages(10-75)
Exclusion
- pregnancy,
- lactation,
- patients under or previous phototherapy,
- patients on other immunosuppressives,
- patients receiving topical or systemic therapy like antioxidants and vitamins were kept off treatment for 2 weeks prior to recruitment into the study.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06546059
Start Date
August 1 2024
End Date
November 1 2024
Last Update
August 9 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.